Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis

International Journal of Molecular Sciences

Volumn 13, Issue 8, 2012, Pages 9959-9970

  Lokman, Noor A ^a   Elder, Alison S F ^a   Ricciardelli, Carmela ^a   Oehler, Martin K ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Chick chorioallantoic membrane; Invasion; Metastasis; Ovarian cancer

Indexed keywords

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOASSAY; CANCER CELL; CANCER INVASION; CELL MOTILITY; CHICK; CHICK CHORIOALLANTOIC MEMBRANE ASSAY; CHORIOALLANTOIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG SCREENING; EMBRYO; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; METASTASIS; MONITORING; NONHUMAN; OVARY CANCER; ANIMAL; APOPTOSIS; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; CHICK EMBRYO; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MOUSE; OVARIAN NEOPLASMS; PATHOLOGY; TUMOR CELL CULTURE; TUMOR INVASION;

NEUTRALIZING ANTIBODY; STAPHYLOCOCCUS PROTEIN A;

ANIMALS; ANTIBODIES, NEUTRALIZING; APOPTOSIS; BIOLOGICAL ASSAY; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; STAPHYLOCOCCAL PROTEIN A; TUMOR CELLS, CULTURED;

EID: 84865041687     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13089959     Document Type: Article

References (37)

1. Lengyel, E. Ovarian cancer development and metastasis. Am. J. Pathol. 2010, 177, 1053-1064.
2. Richardson, M.; Singh, G. Observations on the use of the avian chorioallantoic membrane (CAM) model in investigations into angiogenesis. Curr. Drug Targets-Cardiovasc. Hematol. Disord. 2003, 3, 155-185.
3. Deryugina, E.I.; Quigley, J.P. Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis. Histochem. Cell Biol. 2008, 130, 1119-1130.
4. Tufan, A.C.; Satiroglu-Tufan, N.L. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents. Curr. Cancer Drug Targets 2005, 5, 249-266.
5. Ossowski, L. In vivo invasion of modified chorioallantoic membrane by tumor cells: The role of cell surface-bound urokinase. J. Cell Biol. 1988, 107, 2437-2445.
6. Zhai, Y.; Kuick, R.; Nan, B.; Ota, I.; Weiss, S.J.; Trimble, C.L.; Fearon, E.R.; Cho, K.R. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res. 2007, 67, 10163-10172.
7. Cimpean, A.M.; Ribatti, D.; Raica, M. The chick embryo chorioallantoic membrane as a model to study tumor metastasis. Angiogenesis 2008, 11, 311-319.
8. Valdes, T.I.; Kreutzer, D.; Moussy, F. The chick chorioallantoic membrane as a novel in vivo model for the testing of biomaterials. J. Biomed. Mater. Res. 2002, 62, 273-282.
9. Giannopoulou, E.; Katsoris, P.; Hatziapostolou, M.; Kardamakis, D.; Kotsaki, E.; Polytarchou, C.; Parthymou, A.; Papaioannou, S.; Papadimitriou, E. X-Rays modulate extracellular matrix in vivo. Int. J. Cancer 2001, 94, 690-698.
10. Subauste, M.C.; Kupriyanova, T.A.; Conn, E.M.; Ardi, V.C.; Quigley, J.P.; Deryugina, E.I. Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems. Clin. Exp. Metastasis 2009, 26, 1033-1047.
11. Demir, R.; Dimmler, A.; Naschberger, E.; Demir, I.; Papadopoulos, T.; Melling, N.; Sturzl, M.; Hohenberger, W. Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front. Exp. Mol. Pathol. 2009, 87, 109-116.
12. Strojnik, T.; Kavalar, R.; Barone, T.A.; Plunkett, R.J. Experimental model and mmunohistochemical comparison of U87 human glioblastoma cell xenografts on the chicken chorioallantoic membrane and in rat brains. Anticancer Res. 2010, 30, 4851-4860.
13. Balciuniene, N.; Tamasauskas, A.; Valanciute, A.; Deltuva, V.; Vaitiekaitis, G.; Gudinaviciene, I.; Weis, J.; von Keyserlingk, D.G. Histology of human glioblastoma transplanted on chicken chorioallantoic membrane. Medicina (Kaunas) 2009, 45, 123-131.
14. Hagedorn, M.; Javerzat, S.; Gilges, D.; Meyre, A.; de Lafarge, B.; Eichmann, A.; Bikfalvi, A. Accessing key steps of human tumor progression in vivo by using an avian embryo model. Proc. Natl. Acad. Sci. USA 2005, 102, 1643-1648.
15. Kobayashi, T.; Koshida, K.; Endo, Y.; Imao, T.; Uchibayashi, T.; Sasaki, T.; Namiki, M. A chick embryo model for metastatic human prostate cancer. Eur. Urol. 1998, 34, 154-160.
16. Wittig-Blaich, S.M.; Kacprzyk, L.A.; Eismann, T.; Bewerunge-Hudler, M.; Kruse, P.; Winkler, E.; Strauss, W.S.; Hibst, R.; Steiner, R.; Schrader, M., et al. Matrix-dependent regulation of AKT in Hepsin-overexpressing PC3 prostate cancer cells. Neoplasia 2011, 13, 579-589.
17. Conn, E.M.; Botkjaer, K.A.; Kupriyanova, T.A.; Andreasen, P.A.; Deryugina, E.I.; Quigley, J.P. Comparative analysis of metastasis variants derived from human prostate carcinoma cells: Roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion. Am. J. Pathol. 2009, 175, 1638-1652.
18. Taizi, M.; Deutsch, V.R.; Leitner, A.; Ohana, A.; Goldstein, R.S. A novel and rapid in vivo system for testing therapeutics on human leukemias. Exp. Hematol. 2006, 34, 1698-1708.
19. Balke, M.; Neumann, A.; Kersting, C.; Agelopoulos, K.; Gebert, C.; Gosheger, G.; Buerger, H.; Hagedorn, M. Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane. BMC Res. Notes 2010, 3, doi:10.1186/1756-0500-3-58.
20. Chang, H.L.; Pieretti-Vanmarcke, R.; Nicolaou, F.; Li, X.; Wei, X.; MacLaughlin, D.T.; Donahoe, P.K. Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines. Gynecol. Oncol. 2011, 120, 128-134.
21. Ween, M.P.; Lokman, N.A.; Hoffmann, P.; Rodgers, R.J.; Ricciardelli, C.; Oehler, M.K. Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. Int. J. Cancer 2011, 128, 1570-1584.
22. Lokman, N.A.; Ween, M.P.; Oehler, M.K.; Ricciardelli, C. The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron. 2011, 4, 199-208.
23. Deryugina, E.I.; Quigley, J.P. Chapter 2. Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules. Methods Enzymol. 2008, 444, 21-41.
24. Manenti, L.; Riccardi, E.; Marchini, S.; Naumova, E.; Floriani, I.; Garofalo, A.; Dossi, R.; Marrazzo, E.; Ribatti, D.; Scanziani, E., et al. Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy. Mol. Cancer Ther. 2005, 4, 715-725.
25. Fang, J.; Zhou, Q.; Liu, L.Z.; Xia, C.; Hu, X.; Shi, X.; Jiang, B.H. Apigenin inhibits tumor angiogenesis through decreasing HIF-1α and VEGF expression. Carcinogenesis 2006, 28, 858-864.
26. Luo, H.; Rankin, G.O.; Liu, L.; Daddysman, M.K.; Jiang, B.H.; Chen, Y.C. Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr. Cancer 2009, 61, 554-563.
27. Liu, L.Z.; Jing, Y.; Jiang, L.L.; Jiang, X.E.; Jiang, Y.; Rojanasakul, Y.; Jiang, B.H. Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1alpha pathway. Biochem. Biophys. Res. Commun. 2011, 413, 299-305.
28. Kisker, O.; Onizuka, S.; Banyard, J.; Komiyama, T.; Becker, C.M.; Achilles, E.G.; Barnes, C.M.; O'Reilly, M.S.; Folkman, J.; Pirie-Shepherd, S.R. Generation of multiple angiogenesis inhibitors by human pancreatic cancer. Cancer Res. 2001, 61, 7298-7304.
29. Petitclerc, E.; Brooks, P.C. The chick embryo metastasis model. Methods Mol. Med. 2001, 58, 173-187.
30. Zijlstra, A.; Mellor, R.; Panzarella, G.; Aimes, R.T.; Hooper, J.D.; Marchenko, N.D.; Quigley, J.P. A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Res. 2002, 62, 7083-7092.
31. Aguirre-Ghiso, J.A.; Ossowski, L.; Rosenbaum, S.K. Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res. 2004, 64, 7336-7345.
32. Lyu, M.A.; Choi, Y.K.; Park, B.N.; Kim, B.J.; Park, I.K.; Hyun, B.H.; Kook, Y.H. Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice. Int. J. Cancer 1998, 77, 257-263.
33. Ray, P.; Lewin, S.A.; Mihalko, L.A.; Schmidt, B.T.; Luker, K.E.; Luker, G.D. Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4. Neoplasia (New York, NY, USA) 2011, 13, 1152-1161.
34. Sale, S.; Orsulic, S. Models of ovarian cancer metastasis: Murine models. Drug Discov. Today Dis. Models 2006, 3, 149-154.
35. Bekes, E.M.; Deryugina, E.I.; Kupriyanova, T.A.; Zajac, E.; Botkjaer, K.A.; Andreasen, P.A.; Quigley, J.P. Activation of pro-uPA is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cells. Neoplasia 2011, 13, 806-821.
36. Mullany, L.K.; Richards, J.A.S. Minireview: Animal models and mechanisms of ovarian cancer development. Endocrinology 2012, 153, 1585-1592.
37. Ween, M.P.; Hummitzsch, K.; Rodgers, R.J.; Oehler, M.K.; Ricciardelli, C. Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides. Clin. Exp. Metastasis 2011, 28, 113-125.